Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Other Non-Current Assets (2016 - 2025)

Tvardi Therapeutics' Other Non-Current Assets history spans 11 years, with the latest figure at $17000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 99.4% to $17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $17000.0, a 99.4% decrease, with the full-year FY2025 number at $17000.0, down 99.4% from a year prior.
  • Other Non-Current Assets hit $17000.0 in Q4 2025 for Tvardi Therapeutics, roughly flat from $17000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for TVRD hit a ceiling of $2.8 million in Q4 2024 and a floor of $17000.0 in Q2 2025.
  • Historically, Other Non-Current Assets has averaged $826125.0 across 5 years, with a median of $408000.0 in 2021.
  • Biggest five-year swings in Other Non-Current Assets: surged 267.65% in 2023 and later crashed 99.4% in 2025.
  • Tracing TVRD's Other Non-Current Assets over 5 years: stood at $408000.0 in 2021, then changed by 0.0% to $408000.0 in 2022, then surged by 267.65% to $1.5 million in 2023, then skyrocketed by 87.4% to $2.8 million in 2024, then crashed by 99.4% to $17000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for TVRD at $17000.0 in Q4 2025, $17000.0 in Q3 2025, and $17000.0 in Q2 2025.